COMPANY
Cyanotech
Timeline
- Trial start Not phased (device or behavioral study): Astaxanthin Formulation Bioavailability source ↗
Clinical trials (lead sponsor) 1
| Record | Title | Phase | Status | Start | Primary completion |
|---|---|---|---|---|---|
| NCT02397811 | Astaxanthin Formulation Bioavailability | Not phased (device or behavioral study) | Completed | 2015-06 | 2015-12 (actual) |
NIH awards 1
- NIH award 1R43AI047554-01 FY2000: $90,630 awarded for that fiscal year; activity R43 (SBIR); PI FRANKLIN, SCOTT E; recipient as written: CYANOTECH CORPORATION, KAILUA KONA, HI. EXPRESSION OF THE CYTA TOXIN OF BTI IN source ↗